T 0529/94 (Blood substitutes/D.LONG) vom 09.10.1997
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:1997:T052994.19971009
- Datum der Entscheidung
- 9. Oktober 1997
- Aktenzeichen
- T 0529/94
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 87300248.9
- IPC-Klasse
- A61K 9/10
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden verteilt (C)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Fluorocarbon blood substitutes
- Name des Antragstellers
- ALLIANCE PHARMACEUTICAL CORP.
- Name des Einsprechenden
- -
- Kammer
- 3.3.02
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 123(2) 1973European Patent Convention R 67 1973European Patent Convention R 86(3) 1973
- Schlagwörter
- Amendments (yes) - late submitted amendments disclosed in the filed application
Procedural violation (no) - sufficient reasons to exercise the discretion provided for by Rule 86(3)
Second oral proceedings correctly denied - Orientierungssatz
- -
- Zitierte Akten
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
The case is remitted to the department of first instance with the order to grant a patent with the following claims and description:
claims 1 to 23 for all the contracting states except AT and ES, filed on 14 June 1993, and claims 1 to 23 for the contracting states AT and ES, filed on 14 June 1993, with claims 3 and 4 of both sets as amended with the appellants' letter of 11 April 1997 and resubmitted in their entirety by telefax of 15. September 1997; description: pages 1 to 16 as set out in the communication under Rule 51(4) EPC dated 8 June 1993.
2. The request for reimbursement of the appeal fee is refused.